Serum CA-125 tumor marker in endometrial adenocarcinoma

European Journal of Gynaecological Oncology

Volumn 24, Issue 2, 2003, Pages 151-153

  Kukura, V ^a   Zovko, G ^a   Ciglar, S ^a   Markulin Grgic L ^b   Santek F ^b   Podgajski, M ^a   Duic Z ^a  

^a University of Zagreb   (Croatia)

^b Clinic of Oncology and Radiotherapy   (Croatia)

Author keywords

CA 125; Endometrial cancer

Indexed keywords

CA 125 ANTIGEN; MONOCLONAL ANTIBODY; TUMOR MARKER;

ADULT; CANCER DIAGNOSIS; CLIMACTERIUM; CONFERENCE PAPER; ENDOMETRIUM CARCINOMA; FEMALE; GYNECOLOGIC CANCER; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; RADIOIMMUNOASSAY; SALPINGOOOPHORECTOMY; UTERUS CANCER; VAGINA BLEEDING;

ADENOCARCINOMA; AGED; CA-125 ANTIGEN; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTEROSCOPY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 0037245312     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. Bast R. C. et al.: "A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer". N. Engl. J. Med., 1983, 309, 883.
2. Niloff J. M., Klug T. L., Schaetzl E., Zurawski V. R., Knapp R. C., Bast R. C.: "Elevation of serum CA-125 in carcinomas of the fallopian tube, endometrium, and endocervix". Am. J. Obstet. Gynecol., 1984, 15, 1057.
3. Sood A. K., Buller R. E., Burger R. A., Dawson J. D., Sorosky J. I., Berman M.: "Value of preoperative Ca 125 level in the management of uterine cancer and prediction of clinical outcome". Obstet. Gynecol., 1997, 90 (3), 441.
4. Kurihara T., Mizunuma H., Obara M., Andoh K., Ibuki Y., Nishimura T.: "Determination of a normal level serum CA-125 in post-menopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma". Gynecol. Oncol., 1998, 69 (3), 192.
5. Dotters D. J.: "Preoperative CA 125 in endometrial cancer: is it useful?". Am. J. Obstet. Gynecol., 2000, 182 (6), 1328.
6. Koper N. P., Massuger L. F., Thomas C. M., Kiemeney L. A., Verbeek A. L.: "Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy". Anticancer Research., 1998, 18 (3B), 1897.
7. Kukura V., Zaninović I., Hrdina B.: "Concentrations of CA-125 tumor marker in endometrial carcionoma". Gynecol. Oncol., 1990, 37, 388.
8. Patsner B.: "Endometrial cancer in women 45 years of age or younger". Eur. J. Gynecol. Oncol., 2000, 21 (3), 249.
9. Yabushita H., Shimazu M., Yamada H., Sawaguchi K., Noguchi M., Nakanishi M., Kawai M.: "Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer". Gynecol. Oncol., 2001, 80 (2), 139.
10. Fujimura H., Kikkiawa E, Oguchi H., Nakashima N., Mizutani S.: "Adjuvant chemotherapy including cisplatin in endometrial carcinoma". Gynecol. Obstet. Invest., 2000, 50 (2), 127.
11. Lo S. S., Khoo U. S., Cheng D. K., Ng T. Y., Wong L. C., Ngan H. Y.: "Role of serial tumor markers in the surveillance for recurrence in endometrial cancer". Cancer Detect. Prevent., 1999, 23 (5), 397.
12. Cherchi P. L., Dessole S., Ruiu G. A., Ambrosini G., Farina M., Capobianco G., Ambrosini A.: "The value of serum CA 125 and association CA 125/CA 19-9 in endometrial carcinoma". Eur. J. Gynaecol. Oncol., 1999, 20 (4), 315.
13. Alcazar J. L., Jurado M., Lopez-Garcia G.: "Comparative study of transvaginal ultrasonography and CA 125 in the preoperative evaluation of myometral invasion in endometrial carcinoma". Ultrasound Obstet. Gynecol., 1999, 14 (3), 210.
14. Hardesty L. A., Sumkin J. H., Hakim C., Johns C., Nath M.: "The ability of helical CT to preoperatively stage endometrial carcinoma". A. J. R. Am. J. Roentgen., 2001, 176 (3), 603.
15. Marchetti M., Litta P., Lanza P., Lauri F., Pozzan C.: "The role of hysteroscopiy in early diagnosis of endometrial cancer". Eur. J. Gynaecol. Oncol., 2002, 23 (2), 151.